$AMPE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ampio Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ampio Pharmaceuticals, Inc.. Get notifications about new insider transactions in Ampio Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | M | 0.43 | 35,000 | 15,050 | 283,000 | |
May 19 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Sell | S | 1.83 | 35,000 | 63,980 | 28,315 | 63.3 K to 28.3 K (-55.28 %) |
May 19 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Buy | M | 0.43 | 35,000 | 15,050 | 63,315 | 28.3 K to 63.3 K (+123.61 %) |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | M | 0.40 | 20,000 | 8,000 | 10,000 | ||
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Sell | S | 2.00 | 20,000 | 40,000 | 203,500 | 223.5 K to 203.5 K (-8.95 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Buy | M | 0.40 | 20,000 | 8,000 | 223,500 | 203.5 K to 223.5 K (+9.83 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | M | 0.40 | 3,263 | 1,305 | 6,737 | ||
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Sell | S | 2.00 | 3,263 | 6,526 | 203,500 | 206.8 K to 203.5 K (-1.58 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Buy | M | 0.40 | 3,263 | 1,305 | 206,763 | 203.5 K to 206.8 K (+1.60 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | M | 0.51 | 44,631 | 22,762 | 155,369 | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | M | 0.51 | 30,000 | 15,300 | 0 | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Sell | S | 2.00 | 74,631 | 149,262 | 0 | 74.6 K to 0 (-100.00 %) |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Buy | M | 0.51 | 44,631 | 22,762 | 74,631 | 30 K to 74.6 K (+148.77 %) |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | M | 0.40 | 20,000 | 8,000 | 10,000 | ||
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Sell | S | 2.00 | 20,000 | 40,000 | 203,500 | 223.5 K to 203.5 K (-8.95 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Buy | M | 0.40 | 20,000 | 8,000 | 223,500 | 203.5 K to 223.5 K (+9.83 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | M | 0.40 | 3,263 | 1,305 | 6,737 | ||
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Sell | S | 2.00 | 3,263 | 6,526 | 203,500 | 206.8 K to 203.5 K (-1.58 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Buy | M | 0.40 | 3,263 | 1,305 | 206,763 | 203.5 K to 206.8 K (+1.60 %) | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | M | 0.51 | 44,631 | 22,762 | 155,369 | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | M | 0.51 | 30,000 | 15,300 | 0 | |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Sell | S | 2.00 | 74,631 | 149,262 | 0 | 74.6 K to 0 (-100.00 %) |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Buy | M | 0.51 | 44,631 | 22,762 | 74,631 | 30 K to 74.6 K (+148.77 %) |
Apr 29 2021 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
Mar 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | M | 0.43 | 40,000 | 17,200 | 318,000 | |
Mar 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Sell | S | 1.83 | 40,000 | 73,048 | 28,315 | 68.3 K to 28.3 K (-58.55 %) |
Mar 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Buy | M | 0.43 | 40,000 | 17,200 | 68,315 | 28.3 K to 68.3 K (+141.27 %) |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | M | 0.59 | 10,500 | 6,166 | 19,500 | |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | M | 0.59 | 10,500 | 6,166 | 19,500 | |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | M | 0.43 | 42,000 | 18,060 | 358,000 | |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | M | 0.43 | 42,000 | 18,060 | 358,000 | |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Payment of Exercise | F | 2.55 | 24,185 | 61,672 | 28,315 | 52.5 K to 28.3 K (-46.07 %) |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Payment of Exercise | F | 2.55 | 24,185 | 61,672 | 28,315 | 52.5 K to 28.3 K (-46.07 %) |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Buy | M | 2.55 | 10,500 | 26,775 | 52,500 | 42 K to 52.5 K (+25.00 %) |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Buy | M | 2.55 | 10,500 | 26,775 | 52,500 | 42 K to 52.5 K (+25.00 %) |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Buy | M | 2.55 | 42,000 | 107,100 | 42,000 | 0 to 42 K |
Feb 17 2021 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Buy | M | 2.55 | 42,000 | 107,100 | 42,000 | 0 to 42 K |
Jan 05 2021 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Grant | A | 1.48 | 13,513 | 19,999 | 314,866 | 301.4 K to 314.9 K (+4.48 %) | |
Jan 05 2021 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Grant | A | 1.48 | 13,513 | 19,999 | 203,500 | 190 K to 203.5 K (+7.11 %) | |
Jan 05 2021 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Grant | A | 1.48 | 13,513 | 19,999 | 134,562 | 121 K to 134.6 K (+11.16 %) | |
Dec 21 2020 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | A | 1.78 | 20,000 | 35,600 | 20,000 | |
Dec 21 2020 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | A | 1.78 | 55,000 | 97,900 | 65,000 | |
Dec 21 2020 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | D | 8.62 | 70,598 | 608,555 | 0 | |
Dec 21 2020 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | A | 1.78 | 10,000 | 17,800 | 10,000 | |
Dec 21 2020 | AMPE | Ampio Pharmaceutic ... | MACALUSO MICHAEL | CEO | Option Exercise | A | 1.78 | 50,000 | 89,000 | 50,000 | |
Dec 15 2020 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | A | 1.50 | 36,000 | 54,000 | 36,000 | ||
Dec 15 2020 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | A | 1.50 | 36,000 | 54,000 | 36,000 | ||
Dec 15 2020 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Option Exercise | A | 1.50 | 36,000 | 54,000 | 36,000 | ||
Dec 15 2020 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Option Exercise | A | 1.50 | 36,000 | 54,000 | 36,000 | ||
Nov 18 2020 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Option Exercise | A | 0.79 | 300,000 | 235,800 | 300,000 | ||
Nov 18 2020 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Option Exercise | A | 0.79 | 300,000 | 235,800 | 300,000 | ||
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | A | 0.65 | 212,500 | 138,125 | 212,500 | ||
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | D | 1.70 | 30,000 | 51,000 | 0 | ||
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | D | 1.03 | 220,000 | 226,600 | 0 | ||
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | A | 0.65 | 136,471 | 88,706 | 136,471 | ||
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | D | 1.03 | 160,554 | 165,371 | 0 | ||
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | MACALUSO MICHAEL | CEO | Option Exercise | A | 0.65 | 255,000 | 165,750 | 255,000 | |
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | MACALUSO MICHAEL | CEO | Option Exercise | D | 1.70 | 80,000 | 136,000 | 0 | |
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | MACALUSO MICHAEL | CEO | Option Exercise | D | 1.03 | 220,000 | 226,600 | 0 | |
Jul 06 2020 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Option Exercise | A | 0.61 | 200,000 | 122,000 | 200,000 | ||
Jan 14 2020 | AMPE | Ampio Pharmaceutic ... | MACALUSO MICHAEL | CEO | Option Exercise | A | 0.68 | 200,000 | 135,580 | 200,000 | |
Jan 06 2020 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Grant | A | 0.59 | 34,059 | 19,999 | 121,049 | 87 K to 121 K (+39.15 %) | |
Jan 06 2020 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Grant | A | 0.59 | 34,059 | 19,999 | 189,987 | 155.9 K to 190 K (+21.84 %) | |
Jan 06 2020 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Grant | A | 0.59 | 34,059 | 19,999 | 79,287 | 45.2 K to 79.3 K (+75.31 %) | |
Jan 06 2020 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Grant | A | 0.59 | 34,059 | 19,999 | 301,353 | 267.3 K to 301.4 K (+12.74 %) | |
Jan 06 2020 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | A | 0.59 | 30,000 | 17,616 | 30,000 | |
Dec 23 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Option Exercise | A | 0.47 | 36,000 | 16,740 | 36,000 | ||
Dec 23 2019 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Option Exercise | A | 0.47 | 36,000 | 16,740 | 36,000 | ||
Oct 21 2019 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Option Exercise | A | 0.44 | 30,000 | 13,266 | 30,000 | ||
Oct 21 2019 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Grant | A | 0.44 | 45,228 | 20,000 | 45,228 | 0 to 45.2 K | |
Sep 18 2019 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | A | 0.51 | 200,000 | 102,000 | 200,000 | |
Sep 18 2019 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | CHIEF OPERATING OFF ... | Option Exercise | A | 0.51 | 200,000 | 102,000 | 200,000 | |
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | A | 0.75 | 365,500 | 274,125 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | D | 3.33 | 30,000 | 99,900 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | D | 6.96 | 70,000 | 487,200 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | D | 3.95 | 80,000 | 316,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | D | 2.76 | 100,000 | 276,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Option Exercise | D | 2.50 | 150,000 | 375,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | A | 0.75 | 369,750 | 277,313 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | D | 3.33 | 30,000 | 99,900 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | D | 3.46 | 50,000 | 173,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | D | 2.76 | 75,000 | 207,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | D | 2.76 | 100,000 | 276,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | D | 2.50 | 150,000 | 375,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Option Exercise | D | 1.70 | 30,000 | 51,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Option Exercise | A | 0.75 | 216,750 | 162,563 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Option Exercise | D | 3.33 | 30,000 | 99,900 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Option Exercise | D | 2.76 | 100,000 | 276,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Option Exercise | D | 7.68 | 25,000 | 192,000 | 0 | ||
Sep 11 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Option Exercise | D | 5.55 | 100,000 | 555,000 | 0 | ||
Aug 22 2019 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | A | 0.43 | 400,000 | 172,000 | 400,000 | |
Aug 22 2019 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | D | 0.39 | 430,000 | 167,141 | 0 | |
Aug 01 2019 | AMPE | Ampio Pharmaceutic ... | STOKELY DAN | CFO | Option Exercise | A | 0.39 | 430,000 | 167,141 | 430,000 | |
Jan 09 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Option Exercise | A | 0.40 | 30,000 | 12,000 | 30,000 | |
Jan 09 2019 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Option Exercise | A | 0.40 | 30,000 | 12,000 | 30,000 | |
Jan 09 2019 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Option Exercise | A | 0.40 | 30,000 | 12,000 | 30,000 | |
Jan 04 2019 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Grant | A | 0.44 | 45,454 | 20,000 | 86,990 | 41.5 K to 87 K (+109.43 %) |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Chilcott, III Thomas E. | Chief Financial Off ... | Option Exercise | A | 0.75 | 75,000 | 56,250 | 75,000 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Chilcott, III Thomas E. | Chief Financial Off ... | Option Exercise | D | 0.94 | 75,000 | 70,500 | 0 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | A | 0.75 | 9,402 | 7,052 | 9,402 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | D | 8.62 | 9,402 | 81,045 | 0 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | A | 0.75 | 35,000 | 26,250 | 35,000 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | D | 4.16 | 35,000 | 145,600 | 0 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | A | 0.75 | 170,000 | 127,500 | 170,000 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | D | 1.03 | 170,000 | 175,100 | 0 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | A | 0.75 | 30,000 | 22,500 | 30,000 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | D | 3.43 | 30,000 | 102,900 | 0 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | A | 0.75 | 45,000 | 33,750 | 45,000 | |
Oct 02 2018 | AMPE | Ampio Pharmaceutic ... | Cherevka Holli | Chief Operating Off ... | Option Exercise | D | 4.72 | 45,000 | 212,400 | 0 | |
Sep 24 2018 | AMPE | Ampio Pharmaceutic ... | Chilcott, III Thomas E. | Chief Financial Off ... | Option Exercise | A | 0.51 | 75,000 | 38,250 | 75,000 | |
Jan 29 2018 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Grant | A | 3.48 | 5,747 | 20,000 | 41,536 | 35.8 K to 41.5 K (+16.06 %) |
Jan 29 2018 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Grant | A | 3.48 | 5,747 | 20,000 | 221,840 | 216.1 K to 221.8 K (+2.66 %) |
Jan 29 2018 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Grant | A | 3.48 | 5,747 | 20,000 | 110,474 | 104.7 K to 110.5 K (+5.49 %) |
Sep 28 2017 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Option Exercise | A | 0.60 | 30,000 | 18,000 | 30,000 | |
Sep 28 2017 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Option Exercise | A | 0.60 | 30,000 | 18,000 | 30,000 | |
Sep 28 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Option Exercise | A | 0.60 | 30,000 | 18,000 | 30,000 | |
Sep 28 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Buy | P | 0.63 | 10,000 | 6,270 | 104,727 | 94.7 K to 104.7 K (+10.56 %) |
Sep 22 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Buy | P | 0.60 | 3,000 | 1,800 | 94,727 | 91.7 K to 94.7 K (+3.27 %) |
Sep 22 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Buy | P | 0.59 | 1,000 | 592 | 91,727 | 90.7 K to 91.7 K (+1.10 %) |
Sep 21 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Buy | P | 0.57 | 15,000 | 8,519 | 90,727 | 75.7 K to 90.7 K (+19.81 %) |
Sep 06 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Sell | P | 0.56 | 30,000 | 16,776 | 75,727 | 105.7 K to 75.7 K (-28.37 %) |
Aug 30 2017 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Chief Scientific Of ... | Option Exercise | A | 0.50 | 133,000 | 66,500 | 133,000 | |
Aug 29 2017 | AMPE | Ampio Pharmaceutic ... | Chilcott, III Thomas E. | Chief Financial Off ... | Option Exercise | A | 0.48 | 200,000 | 96,000 | 200,000 | |
Mar 13 2017 | AMPE | Ampio Pharmaceutic ... | MACALUSO MICHAEL | Chief Executive Off ... | Option Exercise | A | 0.81 | 400,000 | 324,000 | 400,000 | |
Jan 09 2017 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
Jan 09 2017 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
Jan 09 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
Jan 05 2017 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Grant | A | 0.96 | 20,826 | 19,999 | 35,789 | 15 K to 35.8 K (+139.18 %) |
Jan 05 2017 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Grant | A | 0.96 | 20,826 | 19,999 | 216,093 | 195.3 K to 216.1 K (+10.67 %) |
Jan 05 2017 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Grant | A | 0.96 | 20,826 | 19,999 | 45,727 | 24.9 K to 45.7 K (+83.64 %) |
Jul 19 2016 | AMPE | Ampio Pharmaceutic ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 1.03 | 150,000 | 154,500 | 416,666 | |
Jan 06 2016 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Grant | A | 3.31 | 6,042 | 19,999 | 14,963 | 8.9 K to 15 K (+67.73 %) |
Jan 06 2016 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Grant | A | 3.31 | 6,042 | 19,999 | 195,267 | 189.2 K to 195.3 K (+3.19 %) |
Jan 06 2016 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Grant | A | 3.31 | 6,042 | 19,999 | 24,901 | 18.9 K to 24.9 K (+32.04 %) |
Dec 15 2015 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Option Exercise | A | 3.33 | 30,000 | 99,900 | 30,000 | |
Dec 15 2015 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Option Exercise | A | 3.33 | 30,000 | 99,900 | 30,000 | |
Dec 15 2015 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Option Exercise | A | 3.33 | 30,000 | 99,900 | 30,000 | |
Dec 03 2015 | AMPE | Ampio Pharmaceutic ... | Ampio Pharmaceuticals, Inc. | 10% Owner | Sell | J | 0.00 | 10,399,661 | 0 | 1,226,407 | 11.6 M to 1.2 M (-89.45 %) |
Aug 03 2015 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Chief Scientific Of ... | Option Exercise | A | 2.60 | 300,000 | 780,000 | 300,000 | |
Aug 03 2015 | AMPE | Ampio Pharmaceutic ... | CLIFT VAUGHAN LENNOX | Chief Regulatory Af ... | Option Exercise | A | 2.68 | 170,000 | 455,600 | 170,000 | |
Aug 03 2015 | AMPE | Ampio Pharmaceutic ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 2.60 | 100,000 | 260,000 | 100,000 | |
Jan 06 2015 | AMPE | Ampio Pharmaceutic ... | Stevens David R | Director | Grant | A | 3.75 | 2,666 | 9,998 | 8,921 | 6.3 K to 8.9 K (+42.62 %) |
Jan 06 2015 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Grant | A | 3.75 | 2,666 | 9,998 | 18,859 | 16.2 K to 18.9 K (+16.46 %) |
Jan 06 2015 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Grant | A | 3.75 | 2,666 | 9,998 | 189,225 | 186.6 K to 189.2 K (+1.43 %) |
Dec 23 2014 | AMPE | Ampio Pharmaceutic ... | COELHO PHILIP H | Director | Option Exercise | A | 3.46 | 50,000 | 173,000 | 50,000 | |
Dec 23 2014 | AMPE | Ampio Pharmaceutic ... | MACALUSO MICHAEL | Chief Executive Off ... | Option Exercise | A | 3.46 | 400,000 | 1,384,000 | 400,000 | |
Aug 13 2014 | AMPE | Ampio Pharmaceutic ... | CLIFT VAUGHAN LENNOX | Chief Regulatory Af ... | Option Exercise | A | 6.48 | 170,000 | 1,101,600 | 170,000 | |
Aug 13 2014 | AMPE | Ampio Pharmaceutic ... | Bar-Or David | Chief Scientific Of ... | Option Exercise | A | 6.48 | 300,000 | 1,944,000 | 300,000 | |
Jun 10 2014 | AMPE | Ampio Pharmaceutic ... | Giles Richard B | Director | Option Exercise | A | 6.96 | 70,000 | 487,200 | 70,000 |